Novartis Investigative Site

Cahors 50269

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Psoriatic Arthritis, Rheumatoid Arthritis

Studies at this site

• The Gilenya Pregnancy Registry — Completed
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) — Completed